The 4A’s filed comments in December on proposed regulations by the Centers for Medicare & Medicaid (CMS) that would require all TV advertisements featuring prescription drugs and biological products to include the list price.
Op-ed by Dick O’Brien, EVP–Government Relations, and Alison Pepper, SVP–Government Relations, at 4A’s. Originally published in ADWEEK, November 21, 2018. As the dust settles on the 2018 midterm elections, a few things have come into focus. One is that while this was maybe not a fully blue wave (depends on which historical perspective you use […]